-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Overweight on Enovix, Maintains $25 Price Target

Benzinga·08/13/2026 12:14:58
Listen to the news
Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $25 price target.